Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04038255
Other study ID # 20190328
Secondary ID
Status Recruiting
Phase Phase 4
First received
Last updated
Start date September 28, 2019
Est. completion date September 2024

Study information

Verified date May 2024
Source University of Miami
Contact Taghrid Asfar, MD
Phone 305-243-3826
Email tasfar@miami.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will examine the effect of a mindfulness-based smoking cessation program among cancer survivors.


Recruitment information / eligibility

Status Recruiting
Enrollment 30
Est. completion date September 2024
Est. primary completion date September 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Be 18 years and older - Cancer survivors (based on the NCI definition - "a person is considered to be a survivor from the time of diagnosis until the end of life" National Cancer Institute Dictionary of Cancer Terms, 2014) - Cancer patients currently in active treatment - Have smoked = 5 cigarettes/day in the past year - Be interested in making a quit attempt in the next 30 days - Own a smartphone (apple/android) - Read/speak English - Able to consent - Have no plans to move in the next 3 months - Are not pregnant or planning to be pregnant in the following 3 months Exclusion Criteria: - Have contraindication to NRT (past month myocardial infarction, history of serious arrhythmias/or unstable angina pectoris, dermatological disorder) - Have cognitive/mental health impairment that inhibits mindfulness treatment - Are currently being treated for smoking cessation, alcoholism, or illicit drug use - Are adults unable to consent - Are individuals who are not yet adults - Are pregnant women - Are prisoners

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Nicoderm C-Q Transdermal Product
6 weeks of nicotine replacement therapy patches
Behavioral:
Orientation session
This session will occur 2 weeks before quit date. It will be moderated by a certified instructor in MT, and will last approximately 90 min. During the session, participants will learn the purpose, format, and procedures of the study, provide electronic informed consent which will be audio-recorded with their permission, and complete the baseline assessment.
Craving-to-Quit app
The app is comprised of 22 modules for 22 days, 5-15 minutes each, designed to teach MT using audio, video, and animation. The app also includes other features such as social support (quit friend sign-ups, the tip of the week), activity feed (to track interaction with the app), and my morning stats (to track smoking).
Two brief follow-up phone calls
The first phone call will occur one day before the quit date to remind participants about their quit date and provide support. The second will occur at the end of treatment (around day 60 after quit date) to review progress, provide support, and schedule the 3-month follow-up visit. Each phone call will last approximately 15 minutes.
Group MT sessions
Total of eight group sessions (twice a week) during 4 weeks. The overarching theme of momentary awareness and acceptance of cravings and affect (e.g., stress, anxiety etc.) will be introduced and reinforced in complementary ways throughout the training. Each session will last 45-60 minutes.
Brief advice on quitting smoking
Standard advice on how to quit smoking.
Self-help smoking cessation materials
Written materials on how to quit smoking including contact info for state tobacco quitline.

Locations

Country Name City State
United States St. Jude Children's Research Hospital Memphis Tennessee
United States University of Miami Miami Florida

Sponsors (1)

Lead Sponsor Collaborator
University of Miami

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of participants with confirmed smoking abstinence self-report of not smoking in the past 7-days, not even a puff, confirmed by expired carbon monoxide (CO) level of < 10 ng/ml 3 months
Secondary Change in number of cigarettes smoked per day Self-reported number of cigarettes smoked per day by each participant (Question is: On average, how many cigarettes do you smoke per day?) Baseline, 3 months
Secondary Number of participants with reported relapse Relapse is defined as smoking at least once/week on two consecutive weeks. 3 months
Secondary Usability of the Craving-to-Quit app as assessed by the number of times participant logged in the app How usable participants found the app measured by the absolute number of times logged into the app. 3 months
Secondary Usability of the Craving-to-Quit app as assessed by the number of days of completed app use How usable participants found the app measured by self-reported number of completed days for the app. 3 months
Secondary Usability of the Craving-to-Quit app as assessed by the comfortability with the app How usable participants found the app measured by the comfortability of the app via questionnaire with scores ranging from 0-10 with the higher score indicating increased comfortability with the app. 3 months
Secondary Acceptability Assessed by 3 items "How satisfied were you with the intervention?", "How likely are you to recommend this intervention to a friend?" and "How useful was the intervention?" Each question is scored from 0-10 with the higher score indicating increased acceptability. 3 months
Secondary Feasibility of recruitment as assessed via enrollment rate A feasible recruitment is defined as an enrollment rate of 70% or higher. Baseline
Secondary Attrition Defined as the number of participants not having a final visit at the end of treatment, categories include mortality, withdrawal from the study, transfer to non-study clinics, loss to follow-up without identifiable cause. 3 months
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT05415371 - Persistent Poverty Counties Pregnant Women With Medicaid N/A
Completed NCT04123041 - Characterize the Nicotine Uptake and Subjective Effects With Use of JUUL Electronic Nicotine Delivery Systems N/A
Completed NCT02735382 - EHR-Based and Fax-Based Referral to a Tobacco Quitline: A Comparative Study N/A
Completed NCT02139930 - Project 2: Strategies for Reducing Nicotine Content in Cigarettes N/A
Completed NCT04107779 - Changes in Biomarkers of Cigarette Smoke Exposure After Switching Either Exclusively or Partly to JUUL ENDS N/A
Completed NCT05037656 - Testing a School-Based E-cigarette, Tobacco, and Betel (Areca) Nut Use Prevention Curriculum for Guam Youths N/A
Completed NCT04200157 - Testing the Decoy Effect to Increase Tobacco Treatment Uptake
Enrolling by invitation NCT06042361 - Enhancing Equity in Smoke-free Housing N/A
Completed NCT02841683 - Pragmatic Randomised Controlled Trial Evaluating Effectiveness of a Smoking Cessation e- Intervention " Tabac Info Service " N/A
Completed NCT03151421 - Air Quality Feedback to Reduce Second-hand Smoke (SHS) Exposure in the Home N/A
Completed NCT04104152 - CSD190203: A Study to Determine Subject Puffing Patterns of an Electronic Nicotine Delivery System in an Ambulatory Setting N/A
Recruiting NCT05306158 - Dual Use Approach Bias Training for Nicotine Addiction N/A
Completed NCT04143256 - Evaluating Selected Constituents in the Exhaled Breath Samples N/A
Completed NCT04094363 - CSD190202: Study to Assess Elements of Abuse Liability for Two Electronic Nicotine Delivery Systems N/A
Completed NCT03553992 - An Extended Facebook Intervention for Young Sexual and Gender Minority Smokers N/A
Completed NCT05102786 - CSD210904: Study to Assess Actual Use of a Heated Tobacco Product With Four Non-Combusted Cigarette Variants in Current Adult Smokers
Terminated NCT04396847 - Laboratory Screening of Lorcaserin for Alcohol Use Disorder Phase 2
Completed NCT03694327 - Innovative Digital Therapeutic for Smoking Cessation N/A
Completed NCT05030194 - Comparing Nicotine Delivery, Subjective Effects, and Sensory Experiences of Tobacco Users Using Oral Nicotine Products and Electronic Cigarettes [ZYN Study] N/A
Completed NCT03015597 - Pilot Study of Contingency Management for Smoking Cessation N/A